【24h】

Large intestine

机译:大肠

获取原文
获取原文并翻译 | 示例
           

摘要

In this section, a diverse group of authors, each a recognized expert in their field, addresses a wide range of issues related to colonic health and disease. The reviews are each excellent in their own right; when combined they provide an impressive array of updates on many aspects of pathogenesis, diagnosis and management of colonic disorders. A unifying characteristic of the contributions is their emphasis on translating reports on recent research developments into practical guidelines for the clinician as to how these advances can and will be applied to everyday medical practice. In their excellent discussion of recent advances in Clostridium difficile infection Drs O'Donoghue and Kyne describe the alarming increases in the incidence and severity of this largely nosocomial and iatrogenic disorder. The authors discuss several factors that have been implicated as contributing to recent outbreaks of C. difficile infection not least the emergence of bacterial strains with increased virulence and antibiotic resistance. Host factors and the emergence of cases in populations not traditionally considered to be at risk including children and those not receiving antibiotics is also covered as is the increasing problem of C. difficile infection complicating inflammatory bowel disease (IBD). On the positive side the authors present data from recent clinical trials on promising new antibiotic and immune-based agents for prevention and for treatment.
机译:在本节中,由不同领域的作者组成,每个作者都是各自领域的公认专家,他们涉及与结肠健康和疾病相关的广泛问题。每条评论本身都非常出色;当结合使用时,它们在结肠疾病的发病机理,诊断和管理的许多方面提供了令人印象深刻的更新。这些贡献的一个统一特征是他们强调将最新研究进展的报告转化为临床医生有关这些进展如何以及将如何应用于日常医学实践的实用指南。在关于艰难梭菌感染的最新进展的精彩讨论中,O'Donoghue博士和Kyne博士描述了这种医院和医源性疾病的发病率和严重程度的惊人增加。作者讨论了与最近艰难梭菌感染暴发有关的几个因素,尤其是毒力和抗生素耐药性增加的细菌菌株的出现。还涵盖了宿主因素和传统上不被认为处于危险中的人群(包括儿童和未接受抗生素的人群)的出现,以及艰难梭菌感染并发炎性肠病(IBD)日益严重的问题。从积极的一面来看,作者们提供了来自近期临床试验的数据,这些数据涉及有前途的新型抗生素和基于免疫的预防和治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号